MREO is Mereo BioPharma Group plc (Healthcare) — a non-dividend-paying stock. Trading at $0.25. Market cap: $40M.
Stock snapshot
| Price | $0.25 |
| Market cap | $40M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About MREO
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Related non-dividend companies
Other non-dividend stocks investors research alongside MREO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is MREO's current stock price?
MREO (Mereo BioPharma Group plc) is currently trading at $0.25.
Does MREO pay a dividend?
MREO (Mereo BioPharma Group plc) does not currently pay a regular dividend.
Track MREO in DiviDrip
Add MREO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search MREO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.